Purchase Order FA523623P3130
Award Date 9/9/23
Potential Completion Date 10/23/23
Potential Value $12K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Thailand
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of the Navy Secretary of the Navy Office of Naval Research has awarded a firm fixed price purchase order contract valued at two hundred thirty-one thousand two hundred ninety-two dollars ($231,292) to Illumina, Inc. to provide a NextSEQ1000 sequencing system. The place of performance will be in Washington, D.C. and the period of performance will conclude on November 22, 2023. No set-aside designation was used for this award. As the sole manufacturer of the proprietary sequencing...
- This is a $115,283.93 firm fixed-price purchase order contract awarded by the Department of the Navy's Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is for the provision of TruSeq Nano DNA High-Throughput (HT) Sample Prep Kits, which support next-generation sequencing. This award is part of a larger indefinite delivery contract worth up to $3.3 million that Illumina holds with the Navy's...
- The U.S. Navy's Bureau of Medicine and Surgery awarded a $98,929.70 firm fixed-price purchase order to Illumina, Inc. for a MiSeq i100 Plus System on September 11, 2025. The contract, which originated from a sole-source Special Notice issued by the Naval Health Research Center in San Diego, covers the procurement of the advanced DNA sequencing instrument along with associated installation and operational qualification services. The award was justified under 10 U.S.C. 3204(a)(1) citing the...
- This firm fixed-price purchase order was awarded by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents. The $116,503.92 contract is for the delivery of undisclosed sequencing products and services to support the agency's mission. Illumina has an Indefinite Delivery Contract worth up to $3.3 million with the Navy for providing reagents and controls for various Illumina sequencing platforms used by the Naval...
- The Office of Naval Research awarded a $15,000 firm fixed-price purchase order to Illumina, Inc. on July 10, 2014, for the MiSeq Silver Contract, with completion targeted for July 9, 2015. The contract, which carries no set-aside designation, will be performed in San Diego, California. Illumina, a biotechnology company specializing in genetic sequencing and genomic analysis technologies, will deliver products or services supporting the Navy's research initiatives. The MiSeq platform is one of...
- This is a firm fixed price purchase order contract awarded by the Naval Sea Systems Command (NAVSEA), a Defense agency, to Illumina, Inc. The contract has a ceiling value of $69,157.00 and a completion date of August 26, 2021. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, is providing goods and services to support NAVSEA's nucleic acid sequencing needs, including reagents and controls for MiSeq, iSeq, NextSeq, and NovaSeq6000 sequencing platforms used at...
- This is a $80,778.39 firm fixed price purchase order contract awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of the Navy, to Illumina, Inc. for CAT# MS-102-3003 MISEQ sequencing systems and associated items. The contract has no set-aside designation. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has a history of providing various sequencing platforms and consumables to support genomics research and diagnostic...
- The Department of the Navy Secretary of the Navy Chief Naval Operations awarded a $514,330.93 purchase order contract to Miscellaneous Foreign Awardees - doing business as Federal Egov IAE Initiative - Generic Entity Identifier to PROVIDE SCIEX QTRAP 6500. AB SCIEX PTE LTD. for the place of performance in Thailand. The contract is a firm fixed price order that runs from September 30, 2022 through February 1, 2023 to provide a SCIEX QTRAP 6500 mass spectrometer manufactured by AB SCIEX PTE LTD....
- This is a firm fixed price purchase order contract awarded by the Naval Sea Systems Command to Illumina, Inc. to provide a MiSeq DNA Sequencer for $111,782.23. The contract has no set-aside designation. Illumina is a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, and has previously provided various sequencing systems, reagents, and services to support research and diagnostics across multiple federal agencies. This award is likely part of Illumina's...
- This is a firm fixed price delivery order awarded by the Medical Command (MEDCOM) of the U.S. Department of Defense to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $110,534.40 contract is for the provision of various NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, accompanying reagents and consumables, sample prep kits, sequencing chips, support plans, maintenance services, and bioinformatics products. This delivery order is issued under...